First use of cenerimod, a selective S1P(1) receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study

por Hermann, Viktoria, Batalov, Anastas, Smakotina, Svetlana, Juif, Pierre-Eric, Cornelisse, Peter
Publicado 2019